Uncovering the financial ties of advocates for cancer drug approval
ecancer news: Matthew Abola, a medical student, worked with an Oregon Health and Science University researcher to scrutinize speakers at the Food and Drug Administration’s Oncologic Drugs Advisory Committee. From that, the researchers looked to find out how many had financial ties to an organization that was seeking marketing approval for a drug.
